These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10619510)

  • 21. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer--a review.
    Urschel JD; Ashiku S; Thurer R; Sellke FW
    Dis Esophagus; 2003; 16(2):60-5. PubMed ID: 12823198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
    Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
    J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
    Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M
    Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
    Iyer R; Wilkinson N; Demmy T; Javle M
    Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.
    Burmeister BH; Thomas JM; Burmeister EA; Walpole ET; Harvey JA; Thomson DB; Barbour AP; Gotley DC; Smithers BM
    Eur J Cancer; 2011 Feb; 47(3):354-60. PubMed ID: 21084184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.
    Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J
    Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Larynx-preserving pharyngo-esophagectomy after chemoradiation in the treatment of cancer of the pharyngo-esophageal junction.
    Horváth OP; Cseke L; Kalmár K; Varga G; Horváth G
    Ann Thorac Surg; 2001 Dec; 72(6):2146-7. PubMed ID: 11789824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Okamura A; Watanabe M; Mine S; Kurogochi T; Yamashita K; Hayami M; Imamura Y; Ogura M; Ichimura T; Takahari D; Chin K
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M; Baba Y; Yoshida N; Ishimoto T; Nagai Y; Iwatsuki M; Iwagami S; Baba H
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
    Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
    Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 35. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.
    Stahl M; Wilke H; Stuschke M; Walz MK; Fink U; Molls M; Siewert JR; Schroeder M; Makoski HB; Schmidt U; Seeber S; Vanhoefer U
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):67-72. PubMed ID: 15480782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].
    Lordick F
    Chirurg; 2005 Nov; 76(11):1025-32. PubMed ID: 16220341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer.
    Fujiwara Y; Lee S; Kishida S; Hashiba R; Gyobu K; Takemura M; Osugi H
    Surg Today; 2017 Nov; 47(11):1356-1360. PubMed ID: 28386749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.